Latest News

  • Alkermes to Present at Goldman Sachs 39th Annual Global Healthcare Conference Read More
  • Alkermes Receives $50 Million Payment From Biogen Following Review of Preliminary Gastrointestinal Tolerability Data From the Ongoing BIIB098 Clinical Development Program Read More
  • Alkermes' Corporate Presentation to be Webcast at the Jefferies 2018 Healthcare Conference Read More

Investors

Working at Alkermes